BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2580899)

  • 1. Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells.
    Matsumoto R; Matsumoto M; Mita S; Hitoshi Y; Ando M; Araki S; Yamaguchi N; Tominaga A; Takatsu K
    Immunology; 1989 Jan; 66(1):32-8. PubMed ID: 15493259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation.
    Randall TD; Lund FE; Brewer JW; Aldridge C; Wall R; Corley RB
    Mol Cell Biol; 1993 Jul; 13(7):3929-36. PubMed ID: 8321200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1 can act as a B-cell growth and differentiation factor.
    Pike BL; Nossal GJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8153-7. PubMed ID: 3877937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specific direct interaction of helper T cells and antigen-presenting B cells.
    Kupfer A; Swain SL; Janeway CA; Singer SJ
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6080-3. PubMed ID: 3526350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.
    Takatsu K; Kikuchi Y; Takahashi T; Honjo T; Matsumoto M; Harada N; Yamaguchi N; Tominaga A
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4234-8. PubMed ID: 3495803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody NIM-R3 substitutes for B-cell growth factor.
    Greenwood MR; Parkhouse RM
    Immunology; 1986 Sep; 59(1):7-13. PubMed ID: 3489671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of IL-2 and antigen in the later stages of the primary antibody response.
    Sawada J; Terao T; Leon MA
    Immunology; 1987 Oct; 62(2):199-205. PubMed ID: 3315978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors.
    Namen AE; Schmierer AE; March CJ; Overell RW; Park LS; Urdal DL; Mochizuki DY
    J Exp Med; 1988 Mar; 167(3):988-1002. PubMed ID: 3258354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interleukins in acquired disease.
    Malkovský M; Sondel PM; Strober W; Dalgleish AG
    Clin Exp Immunol; 1988 Nov; 74(2):151-61. PubMed ID: 3066538
    [No Abstract]   [Full Text] [Related]  

  • 10. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue.
    Azuma C; Tanabe T; Konishi M; Kinashi T; Noma T; Matsuda F; Yaoita Y; Takatsu K; Hammarström L; Smith CI
    Nucleic Acids Res; 1986 Nov; 14(22):9149-58. PubMed ID: 3024129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specific direct interaction of helper T cells and antigen-presenting B cells. II. Reorientation of the microtubule organizing center and reorganization of the membrane-associated cytoskeleton inside the bound helper T cells.
    Kupfer A; Swain SL; Singer SJ
    J Exp Med; 1987 Jun; 165(6):1565-80. PubMed ID: 2953845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of gut-associated lymphoid cells by IL-4 and B-cell growth factor II.
    Tonkonogy SL; Swain SL
    Immunology; 1988 May; 64(1):155-61. PubMed ID: 2454884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.
    Harada N; Takahashi T; Matsumoto M; Kinashi T; Ohara J; Kikuchi Y; Koyama N; Severinson E; Yaoita Y; Honjo T
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4581-5. PubMed ID: 2440025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of murine recombinant interleukin-5 on the cell population in guinea-pig airways.
    Iwama T; Nagai H; Suda H; Tsuruoka N; Koda A
    Br J Pharmacol; 1992 Jan; 105(1):19-22. PubMed ID: 1596681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells.
    Swain SL
    J Immunol; 1985 Jun; 134(6):3934-43. PubMed ID: 2580899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation.
    Nakagawa T; Nakagawa N; Goldstein H; Volkman DJ; Fauci AS
    J Immunol; 1986 Nov; 137(10):3175-82. PubMed ID: 2945860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRF requirements for in vitro PFC responses to SRBC and R36a. I. TRF is distinct from IL 2 but indistinguishable from polyclonal BCSF.
    Eisenberg L; Prystowsky MB; Dick RF; Sosman JA; Fitch FW; Quintáns J
    J Immunol; 1984 Mar; 132(3):1305-10. PubMed ID: 6363538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signals in B lymphocyte proliferation and differentiation.
    Schimpl A
    Ann Immunol (Paris); 1983; 134D(1):143-53. PubMed ID: 6354067
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.